Important data from Brazil demonstrating the safety and non inferiority of DOAC therapy in biological mitral valves and atrial fibrillation. This study makes a significant…
View More Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve
Announcement on the staging of the 2021 edition of the BCS Annual Conference
View More BCS Announcement On The Annual Conference 2021
Day Two, as reported by three BCS members in attendance
View More ESC Congress 2020 – The Digital Experience
Day One By Dr Noor Sharrack, Cardiology SpR With public gatherings banned in the Netherlands due to the COVID-19 pandemic, the 2020 edition of the…
View More ESC Congress 2020 – The Digital Experience